Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a monoclonal antibody that depletes CD19+ B cells, which are central to ...

(RTTNews) - Eli Lilly and Company (LLY) Thursday reported topline data from Phase 3 ACHIEVE-1 study of orforglipron in adults with type 2 diabetes. The study met its primary goal. ACHIEVE-1 is the ...

Cofco International, which is building its biggest export port terminal in the world in Brazil, said on Tuesday China's state ...